Microtubules and HER2 — Drug Target

All drugs that target Microtubules and HER2 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Microtubule inhibitor and HER2-targeting monoclonal antibodies

Phase 3 pipeline (1)

• Nab-paclitaxel+ trastuzumab+ patuzumab · Henan Cancer Hospital · Microtubule inhibitor and HER2-targeting monoclonal antibodies · Oncology
  Nab-paclitaxel is a microtubule inhibitor that disrupts cell division, while trastuzumab and pertuzumab are monoclonal antibodies that target the HER2 protein.